AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32281816 — intervention group
Group type: EXPERIMENTAL
Intervention: Family DSME (Diabetes Self-Management Education)
Number of subjects: 142
Study 32281816 — intervention group
Group type: COMPARATOR
Intervention: Standard DSME
Number of subjects: 142
Study 32281816 — intervention group
Group type: EXPERIMENTAL
Intervention: Family DSME
Number of subjects: 142
Study 34936528 — intervention group
Group type: EXPERIMENTAL
Intervention: TranS‐C
Number of subjects: 176
Study 34936528 — intervention group
Group type: EXPERIMENTAL
Intervention: TranS‐C with text messages
Number of subjects: 176
Study 34936528 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation (PE)
Number of subjects: 176
Study 34936528 — intervention group
Group type: EXPERIMENTAL
Intervention: TranS‐C and text messages
Number of subjects: 176
Study 32660667 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral quinine and intragastric placebo (OQGP)
Number of subjects: 32
Study 32660667 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral placebo and intragastric quinine (OPGQ)
Number of subjects: 32
Study 32660667 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo and intragastric placebo (OPGP)
Number of subjects: 32
Study 32660667 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral quinine and intragastric quinine (OQGQ)
Number of subjects: 32
Study 35357449 — intervention group
Group type: EXPERIMENTAL
Intervention: Immune checkpoint inhibitors (ICI)
Number of subjects: 741
Study 35357449 — intervention group
Group type: COMPARATOR
Intervention: Taxane chemotherapy
Number of subjects: 741
Study 32650126 — intervention group
Group type: EXPERIMENTAL
Intervention: Surviving Sepsis Campaign recommendations
Number of subjects: 0
Study 32650126 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation recommendations
Number of subjects: 0
Study 32650126 — intervention group
Group type: EXPERIMENTAL
Intervention: Resuscitation recommendations
Number of subjects: 0
Study 32650126 — intervention group
Group type: EXPERIMENTAL
Intervention: Management/adjuvant therapy recommendations
Number of subjects: 0
Study 32650126 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial/source control recommendations
Number of subjects: 0
Study 32650126 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition recommendations
Number of subjects: 0
Study 34787653 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 519
Study 34787653 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 519
Study 34088230 — intervention group
Group type: EXPERIMENTAL
Intervention: Discrete-time decay model
Number of subjects: 44
Study 34088230 — intervention group
Group type: EXPERIMENTAL
Intervention: Exchangeable, block-exchangeable, and discrete-time decay correlation structures
Number of subjects: 44
Study 34088230 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing period-length and cluster-period sizes
Number of subjects: 44
Study 34088230 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing cluster-period size
Number of subjects: 44
Study 32320043 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Oral Anticoagulants (DOACs)
Number of subjects: 514
Study 32320043 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 514
Study 36065582 — intervention group
Group type: EXPERIMENTAL
Intervention: Forensic Assertive Community Treatment (FACT)
Number of subjects: 70
Study 36065582 — intervention group
Group type: COMPARATOR
Intervention: Outpatient psychiatric treatment including intensive case management
Number of subjects: 70
Study 32951215 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based disability prevention program (up to six 1-hour home visits with an occupational therapist, up to four 1-hour home visits with a registered nurse, and up to $1,300 worth of home repairs, modifications, and assistive devices with a handyman over 4 months)
Number of subjects: 194
Study 32470437 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab 16 mg/kg intravenous once per week for 8 weeks, then twice per month for 8 doses, and once per month until disease progression.
Number of subjects: 148
Study 32470437 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab 16 mg/kg intravenous once per week for 8 weeks, then twice per month for 16 weeks, and once per month until disease progression.
Number of subjects: 148
Study 32470437 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab 16 mg/kg intravenous.
Number of subjects: 148
Study 616874577 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-caloric sweetened beverages (diet)
Number of subjects: 209
Study 616874577 — intervention group
Group type: EXPERIMENTAL
Intervention: Water (water)
Number of subjects: 209
Study 616874577 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 209
Study 36168741 — intervention group
Group type: EXPERIMENTAL
Intervention: Cladribine 3.5 mg/kg
Number of subjects: 532
Study 36168741 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 532
Study 34468885 — intervention group
Group type: EXPERIMENTAL
Intervention: EDP-M (etoposide, doxorubicin, and cisplatin plus mitotane)
Number of subjects: 43
Study 33629193 — intervention group
Group type: EXPERIMENTAL
Intervention: PVI + LAPWI using CB-A
Number of subjects: 120
Study 33629193 — intervention group
Group type: COMPARATOR
Intervention: PVI + linear ablation using RFCA
Number of subjects: 120
Study 33629193 — intervention group
Group type: COMPARATOR
Intervention: PVI alone using CB-A
Number of subjects: 120
Study 33629193 — intervention group
Group type: COMPARATOR
Intervention: PVI alone using RFCA
Number of subjects: 120
Study 34534030 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga program (12 sessions, once per week for 12 weeks)
Number of subjects: 60
Study 34534030 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 33419518 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress recovery intervention
Number of subjects: 0
Study 33419518 — intervention group
Group type: COMPARATOR
Intervention: No additional training (Control)
Number of subjects: 0
Study 35951072 — intervention group
Group type: EXPERIMENTAL
Intervention: Fennel mixed with coarse salt for ironing, combined with umbilical moxibustion
Number of subjects: 96
Study 35951072 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 96
Study 32629469 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual segmentation using Horos software
Number of subjects: 58
Study 32629469 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-automatic segmentation using IPlan software
Number of subjects: 58
Study 32629469 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated segmentation using BraTumIA software
Number of subjects: 58
Study 32629469 — intervention group
Group type: COMPARATOR
Intervention: Manual segmentation
Number of subjects: 58
Study 32629469 — intervention group
Group type: COMPARATOR
Intervention: Semi-automated segmentation
Number of subjects: 58
Study 32629469 — intervention group
Group type: COMPARATOR
Intervention: Automated segmentation
Number of subjects: 58
Study 35994774 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo (N=46)
Number of subjects: 151
Study 35994774 — intervention group
Group type: COMPARATOR
Intervention: Midazolam placebo (N=105)
Number of subjects: 151
Study 34328588 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational book group
Number of subjects: 167
Study 34328588 — intervention group
Group type: COMPARATOR
Intervention: Non-educational book group
Number of subjects: 167
Study 34328588 — intervention group
Group type: COMPARATOR
Intervention: No-book group
Number of subjects: 167
Study 616173210 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation plus heart coherence training (HCT)
Number of subjects: 18
Study 616173210 — intervention group
Group type: COMPARATOR
Intervention: Cardiac rehabilitation (no HCT group)
Number of subjects: 18
Study 35257499 — intervention group
Group type: COMPARATOR
Intervention: HIIT-PLA
Number of subjects: 81
Study 35257499 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT-CIT
Number of subjects: 81
Study 33757499 — intervention group
Group type: EXPERIMENTAL
Intervention: HyFlex EDM glide path file
Number of subjects: 80
Study 33757499 — intervention group
Group type: COMPARATOR
Intervention: PathFile
Number of subjects: 80
Study 32342837 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 334
Study 34380000 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT)
Number of subjects: 18
Study 34380000 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 18
Study 34380000 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 18
Study 33180924 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-drop mOPV2
Number of subjects: 378
Study 33180924 — intervention group
Group type: COMPARATOR
Intervention: 2-drop mOPV2
Number of subjects: 378
Study 33934981 — intervention group
Group type: EXPERIMENTAL
Intervention: POC management based on ROTEM results
Number of subjects: 67
Study 33934981 — intervention group
Group type: COMPARATOR
Intervention: non POC management based on clinical experience
Number of subjects: 67
Study 34097565 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment-oriented group action (AGA) with professional support
Number of subjects: 43
Study 34097565 — intervention group
Group type: COMPARATOR
Intervention: Control group (feedback only)
Number of subjects: 43
Study 33352601 — intervention group
Group type: EXPERIMENTAL
Intervention: Rest redistribution set configuration
Number of subjects: 39
Study 33352601 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional set configuration
Number of subjects: 39
Study 33352601 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study 36057581 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG-based multi-Kalman filter approach
Number of subjects: 10
Study 33428907 — intervention group
Group type: EXPERIMENTAL
Intervention: E4 15 mg/DRSP 3 mg (E4/DRSP)
Number of subjects: 98
Study 33428907 — intervention group
Group type: COMPARATOR
Intervention: Ethinylestradiol (EE) 30 µg/levonorgestrel (LNG)
Number of subjects: 98
Study 33428907 — intervention group
Group type: COMPARATOR
Intervention: EE 20 µg/DRSP 3 mg
Number of subjects: 98
Study 33428907 — intervention group
Group type: COMPARATOR
Intervention: EE 30 µg/LNG 150 µg
Number of subjects: 98
Study 36223288 — intervention group
Group type: EXPERIMENTAL
Intervention: Ahmed FP7 Glaucoma Valve (AGV)
Number of subjects: 43
Study 36223288 — intervention group
Group type: COMPARATOR
Intervention: Baerveldt 101-350 Glaucoma Implant (BGI)
Number of subjects: 43
Study 33616655 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfacalcidol
Number of subjects: 45
Study 33616655 — intervention group
Group type: COMPARATOR
Intervention: Calcitriol
Number of subjects: 45
Study 33048964 — intervention group
Group type: EXPERIMENTAL
Intervention: Facemask use
Number of subjects: 7687
Study 33048964 — intervention group
Group type: COMPARATOR
Intervention: No facemask
Number of subjects: 7687
Study 35107354 — intervention group
Group type: EXPERIMENTAL
Intervention: sMCL augmentation repair
Number of subjects: 54
Study 35107354 — intervention group
Group type: COMPARATOR
Intervention: sMCL reconstruction
Number of subjects: 54
Study 34187228 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine as a sodium channel blocker
Number of subjects: 0
Study 34187228 — intervention group
Group type: EXPERIMENTAL
Intervention: Del Nido Cardioplegia
Number of subjects: 0
Study 34187228 — intervention group
Group type: COMPARATOR
Intervention: Standard cardioplegic techniques
Number of subjects: 0
Study 33197158 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation
Number of subjects: 203
Study 33197158 — intervention group
Group type: COMPARATOR
Intervention: Antiarrhythmic drug therapy
Number of subjects: 203
Study 32647051 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) - 4 × 4‐min HIIT (85‐95% peak heart rate) performed thrice weekly for 12 weeks
Number of subjects: 30
Study 32647051 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 30
Study 34610731 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Exercise (HIE)
Number of subjects: 14
Study 34610731 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Exercise (MCE)
Number of subjects: 14
Study 33755218 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine oral rinse
Number of subjects: 100
Study 33755218 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine oral rinse and oropharyngeal spray
Number of subjects: 100
Study 33755218 — intervention group
Group type: COMPARATOR
Intervention: Standard of care only (control group)
Number of subjects: 100
Study 35458151 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycle Ergometry with Enteral Nutrition (Group 2)
Number of subjects: 41
Study 35458151 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycle Ergometry with Protein-Enriched Enteral Nutrition (Group 3)
Number of subjects: 41
Study 35458151 — intervention group
Group type: COMPARATOR
Intervention: Conventional Physiotherapy with Enteral Nutrition (Control, Group 1)
Number of subjects: 41
Study 35458151 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (Group 1, Group 2, Group 3)
Number of subjects: 41
Study 32376105 — intervention group
Group type: EXPERIMENTAL
Intervention: EAPP training courses (experimental group)
Number of subjects: 70
Study 32376105 — intervention group
Group type: COMPARATOR
Intervention: Originally scheduled activities only (control group)
Number of subjects: 70
Study 34848169 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5 mg every 4 weeks (Rq4)
Number of subjects: 1815
Study 34848169 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflibercept 2 mg every 4 weeks (2q4)
Number of subjects: 1815
Study 34848169 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflibercept 2 mg every 8 weeks after 3 monthly doses (2q8)
Number of subjects: 1815
Study 34848169 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall analysis
Number of subjects: 1815
Study 35325334 — intervention group
Group type: EXPERIMENTAL
Intervention: Victims of bullying
Number of subjects: 5208
Study 35325334 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-victims of bullying)
Number of subjects: 5208
Study 35325334 — intervention group
Group type: EXPERIMENTAL
Intervention: Female students
Number of subjects: 5208
Study 33677463 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 25
Study 32737183 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscimol infusion into the periaqueductal gray (PAG)
Number of subjects: 0
Study 32737183 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion into the PAG
Number of subjects: 0
Study 34928310 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional anesthesia (spinal, epidural, or both techniques combined with no sedation; n=476)
Number of subjects: 950
Study 34928310 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (intravenous, inhalational, or combined anesthetic agents; n=474)
Number of subjects: 950
Study 34928310 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional anesthesia
Number of subjects: 950
Study 34928310 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 950
Study 33198837 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care ultrasound (POCUS) training including a 30-minute lecture and hands-on training
Number of subjects: 60
Study 33198837 — intervention group
Group type: COMPARATOR
Intervention: No POCUS training (Control group)
Number of subjects: 60
Study 33198837 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care ultrasound (POCUS) training
Number of subjects: 60
Study 32241367 — intervention group
Group type: EXPERIMENTAL
Intervention: mAFA intervention
Number of subjects: 3324
Study 32241367 — intervention group
Group type: COMPARATOR
Intervention: usual care
Number of subjects: 3324
Study 34262260 — intervention group
Group type: EXPERIMENTAL
Intervention: TPN171H (5-30 mg dose range)
Number of subjects: 63
Study 34262260 — intervention group
Group type: EXPERIMENTAL
Intervention: TPN171H under fed condition
Number of subjects: 63
Study 34262260 — intervention group
Group type: EXPERIMENTAL
Intervention: TPN171H (multiple dosing)
Number of subjects: 63
Study 34262260 — intervention group
Group type: EXPERIMENTAL
Intervention: TPN171H
Number of subjects: 63
Study 33156923 — intervention group
Group type: EXPERIMENTAL
Intervention: Emicizumab
Number of subjects: 66
Study 33156923 — intervention group
Group type: COMPARATOR
Intervention: ELOCTATE
Number of subjects: 66
Study 37045496 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissolve DCB
Number of subjects: 260
Study 37045496 — intervention group
Group type: COMPARATOR
Intervention: SeQuent Please DCB
Number of subjects: 260
Study 32851466 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote-controlled camera holder (RCH)
Number of subjects: 40
Study 32851466 — intervention group
Group type: COMPARATOR
Intervention: Human camera assistant (HCA)
Number of subjects: 40
Study 35997620 — intervention group
Group type: EXPERIMENTAL
Intervention: mDOT (modified directly observed therapy)
Number of subjects: 150
Study 35997620 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall HCV treatment
Number of subjects: 150
Study 35997620 — intervention group
Group type: COMPARATOR
Intervention: Baseline alcohol consumption
Number of subjects: 150
Study 35997620 — intervention group
Group type: COMPARATOR
Intervention: Overall treatment groups
Number of subjects: 150
Study 35997620 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall days of drinking
Number of subjects: 150
Study 35997620 — intervention group
Group type: COMPARATOR
Intervention: Drinking to intoxication
Number of subjects: 150
Study 33564828 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein supplementation (20 g/d soy protein isolate, providing 41 mg/d total isoflavones and 23 mg/d genistein)
Number of subjects: 93
Study 33564828 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein supplementation
Number of subjects: 93
Study 33564828 — intervention group
Group type: COMPARATOR
Intervention: Casein-based placebo
Number of subjects: 93
Study 32824308 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese Healthy Eating Index (CHEI) assessment
Number of subjects: 404
Study 32824308 — intervention group
Group type: EXPERIMENTAL
Intervention: CHEI scores among ethnic minority groups and women younger than 30 years
Number of subjects: 404
Study 35190534 — intervention group
Group type: EXPERIMENTAL
Intervention: Biannual mass distribution of azithromycin
Number of subjects: 3814
Study 32907814 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk-reducing early salpingectomy with delayed oophorectomy
Number of subjects: 1000
Study 32907814 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk-reducing salpingo-oophorectomy
Number of subjects: 1000
Study 32907814 — intervention group
Group type: COMPARATOR
Intervention: Controls (no surgery)
Number of subjects: 1000
Study 33196579 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy (DAPT)
Number of subjects: 3
Study 33196579 — intervention group
Group type: COMPARATOR
Intervention: Single antiplatelet therapy (not explicitly mentioned but implied as control)
Number of subjects: 3
Study 33228807 — intervention group
Group type: EXPERIMENTAL
Intervention: UVR-sensor wearable device (Shade) with notifications and an informational brochure about sun protection behaviors
Number of subjects: 368
Study 33228807 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving the device without notifications or summary UVR exposure data
Number of subjects: 368
Study 35417027 — intervention group
Group type: EXPERIMENTAL
Intervention: Gold Standard Program (GSP-A)
Number of subjects: 70
Study 35417027 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 70
Study 34783672 — intervention group
Group type: EXPERIMENTAL
Intervention: Granular privacy control
Number of subjects: 270
Study 34783672 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived risk
Number of subjects: 270
Study 34783672 — intervention group
Group type: EXPERIMENTAL
Intervention: Trust in the system
Number of subjects: 270
Study 34783672 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived benefits
Number of subjects: 270
Study 32532221 — intervention group
Group type: EXPERIMENTAL
Intervention: Perturbation-based balance training (PBT)
Number of subjects: 34
Study 32532221 — intervention group
Group type: COMPARATOR
Intervention: Control intervention (general balance exercises)
Number of subjects: 34
Study 35442784 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention arm 'More' (text messages, digital health care workers, community health fair)
Number of subjects: 4342
Study 35442784 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention arm 'Most' (text messages, digital health care workers, community health fair)
Number of subjects: 4342
Study 35442784 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention arm 'Least' (text-only)
Number of subjects: 4342
Study 35442784 — intervention group
Group type: COMPARATOR
Intervention: Preintervention period
Number of subjects: 4342
Study 34390226 — intervention group
Group type: EXPERIMENTAL
Intervention: Testicular cancer patients (TCPs)
Number of subjects: 38
Study 34390226 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (HCs)
Number of subjects: 38
Study 32065508 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous epiduroscopic laser neural disc decompression (ELND) and percutaneous laser disc decompression (PLDD) using Ho:YAG laser
Number of subjects: 41
Study 32778008 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-fortified formula (12.7 mg/L)
Number of subjects: 443
Study 32778008 — intervention group
Group type: COMPARATOR
Intervention: Low-iron formula (2.3 mg/L)
Number of subjects: 443
Study 33034872 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast Self-Examination (BSE) awareness and practice
Number of subjects: 202
Study 33034872 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of screening methods for breast cancer
Number of subjects: 202
Study 33034872 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of risk factors for breast cancer
Number of subjects: 202
Study 33034872 — intervention group
Group type: EXPERIMENTAL
Intervention: Sociodemographic factors influencing BSE practice
Number of subjects: 202